ARCHIVES

Graalman Objects To Criticism On Contract Competition

This article is from The Cancer Letter archive.

Vol. 03 No. 16 | April 22, 1977

Download PDF Visit The Full Archive

Related Articles

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

Two Breast Cancer Screening Methods Found Equivalent

August 29, 2008

New “JNC” Popular Replacement For Old Journals

May 20, 1988

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004